Search results
GlaxoSmithKline (GSK) Stock Moves -0.11%: What You Should Know
Zacks via Yahoo Finance· 2 years agoGlaxoSmithKline (GSK) closed at $44.20 in the latest trading session, marking a -0.11% move from the...
GlaxoSmithKline (GSK) Dips More Than Broader Markets: What You Should Know
Zacks via Yahoo Finance· 2 years agoGlaxoSmithKline (GSK) closed the most recent trading day at $40.92, moving -1.25% from the previous...
2 Dividend Stocks to Double Up On Right Now
Motley Fool· 2 years agoAbbVie (NYSE: ABBV) and GlaxoSmithKline (NYSE: GSK) have much in common. They are huge pharmaceutical companies that have a long record of success,...
Is Arrowhead Pharmaceuticals a Buy Now?
Motley Fool· 1 year agoAre you looking for stocks that can make dramatic moves in a short amount of time? If so, you'll want to check out Arrowhead Pharmaceuticals (NASDAQ:...
Why GlaxoSmithKline Stock Jumped 25% on Thursday
Motley Fool· 2 years agoShares of pharmaceutical company GlaxoSmithKline (NYSE: GSK) rose 25% on Thursday. The company, on Monday, said that its former consumer healthcare division, under the name Haleon, listed on ...
25 Biggest Pharmaceutical Companies in the World A Year Ago
Insider Monkey via Yahoo Finance· 2 years agoIn this article we listed the 25 biggest pharmaceutical companies in the world a year ago and then...
Insider Sell Alert: Marianne Zhen Offloads Shares of Innoviva Inc
GuruFocus.com via Yahoo Finance· 5 months agoIn the realm of stock market movements, insider trading activity is often a significant indicator...
3 Pharmaceutical Stocks That Are Too Cheap to Ignore
Motley Fool· 8 months agoOn average, healthcare stocks haven't kept up with the gains made by the rest of the market this year. Viatris (NASDAQ: VTRS), GSK (NYSE: GSK), and...
Drug/Biotech Stocks Q1 Earnings Due on May 5: VRTX, ZTS & More
Zacks via Yahoo Finance· 2 years agoThe first-quarter 2022 reporting cycle of the Medical sector is currently in full swing. The sector...
Gilead (GILD) Q1 Earnings Beat on Solid COVID Treatment Sales
Zacks via Yahoo Finance· 2 years agoGilead Sciences, Inc. GILD reported strong first-quarter results driven by sales from its antiviral...